The expression levels of miR-5088-5p were increased in both animal models (Fig. 1B) and cells (Fig. 1C) as well as breast and lung cancer patients subjected to radiotherapy (Fig. 1A), Supplementary Fig. S1) while levels of target DBC2 were relatively decreased (Supplementary Fig. S2), supporting our earlier findings. Here, RHOBTB2 is linked to lung cancer.